[go: up one dir, main page]

AU3970697A - Cyclic carbamates and isoxazolidines as iib/iiia antagonists - Google Patents

Cyclic carbamates and isoxazolidines as iib/iiia antagonists

Info

Publication number
AU3970697A
AU3970697A AU39706/97A AU3970697A AU3970697A AU 3970697 A AU3970697 A AU 3970697A AU 39706/97 A AU39706/97 A AU 39706/97A AU 3970697 A AU3970697 A AU 3970697A AU 3970697 A AU3970697 A AU 3970697A
Authority
AU
Australia
Prior art keywords
isoxazolidines
iib
iiia antagonists
cyclic carbamates
carbamates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39706/97A
Inventor
Pasquale Nicholas Confalone
Fuqiang Jin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
DuPont Merck Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DuPont Merck Pharmaceutical Co filed Critical DuPont Merck Pharmaceutical Co
Publication of AU3970697A publication Critical patent/AU3970697A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C07D265/08—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D265/10—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU39706/97A 1996-08-15 1997-08-13 Cyclic carbamates and isoxazolidines as iib/iiia antagonists Abandoned AU3970697A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2422596P 1996-08-15 1996-08-15
US60024225 1996-08-15
US70090696A 1996-08-21 1996-08-21
US08700906 1996-08-21
PCT/US1997/013761 WO1998006707A1 (en) 1996-08-15 1997-08-13 Cyclic carbamates and isoxazolidines as iib/iiia antagonists

Publications (1)

Publication Number Publication Date
AU3970697A true AU3970697A (en) 1998-03-06

Family

ID=26698197

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39706/97A Abandoned AU3970697A (en) 1996-08-15 1997-08-13 Cyclic carbamates and isoxazolidines as iib/iiia antagonists

Country Status (5)

Country Link
EP (1) EP0922039A1 (en)
JP (1) JP2000516230A (en)
AU (1) AU3970697A (en)
CA (1) CA2263311A1 (en)
WO (1) WO1998006707A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4584199A (en) 1998-06-29 2000-01-17 Du Pont Pharmaceuticals Company Cyclic carbamates and isoxazolidines as iib/iiia antagonists
TWI288745B (en) 2000-04-05 2007-10-21 Daiichi Seiyaku Co Ethylenediamine derivatives
NZ596445A (en) * 2009-06-24 2013-04-26 Boehringer Ingelheim Int New compounds, pharmaceutical composition and methods relating thereto

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
DE4124942A1 (en) * 1991-07-27 1993-01-28 Thomae Gmbh Dr K 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENTS CONTAINING SUCH COMPOUNDS
TW223629B (en) * 1992-03-06 1994-05-11 Hoffmann La Roche
DK0730589T3 (en) * 1993-11-24 1999-02-01 Du Pont Pharm Co Isoxazoline Compounds Useful as Fibrinogen Receptor Antagonists
FI962184L (en) * 1993-11-24 1996-05-23 Du Pont Merck Pharma New isoxazoline and isoxazole fibrinogen receptor antagonists
IL118007A0 (en) * 1995-05-24 1996-08-04 Du Pont Merck Pharma Isoxazoline compounds pharmaceutical compositions containing them and their use

Also Published As

Publication number Publication date
EP0922039A1 (en) 1999-06-16
CA2263311A1 (en) 1998-02-19
JP2000516230A (en) 2000-12-05
WO1998006707A1 (en) 1998-02-19

Similar Documents

Publication Publication Date Title
AU2957997A (en) 1,2,4-oxadiazoles as adhesion-receptor antagonists
AU1273195A (en) Tachykinin antagonists
AU1842995A (en) N-acylpiperidine tachykinin antagonists
AU3899997A (en) Muscarinic antagonists
AU4343796A (en) Tachykinin antagonists
AU7689196A (en) Portable trommel
HUP9903657A3 (en) Fungicide mixture
AU5319798A (en) Cyclic imines as pesticides
AU3063597A (en) Polyalkylphenoxyaminoalkanes and fuel compositions containing the same
HUP9903590A3 (en) 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
AU2660900A (en) 4-haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclyl-pyrimidines and their use as repellents
ZA974171B (en) Novel isoxazole derivatives and their use as herbicides
AU2625297A (en) Material based on inorganic fibres
AU2694195A (en) Substituted dibenzoxazepine and dibenzthiazepine carbamates useful as prostaglandin antagonists
AU4584199A (en) Cyclic carbamates and isoxazolidines as iib/iiia antagonists
EP0997144A4 (en) Plasticizer and patch containing the plasticizer
AU4829097A (en) Wooden baseball bat and method
AU4406097A (en) Heterodimer peptides with immunomodulatory effect
AU3970697A (en) Cyclic carbamates and isoxazolidines as iib/iiia antagonists
AU1851797A (en) Cyclic peptide antifungal agents
AU3116697A (en) Human interleukin-1j and antagonists thereof
ZA976248B (en) Cyclic carbamates and isoxazolidines as IIB/IIIA antagonists
AU2202397A (en) Iib/iiia antagonists co-administered with aspirin and/or heparin
AU3616497A (en) Cyclic decapeptide antibiotics
TW338527U (en) Multi-purpose cap and camera-attached cap